{"disease":{"id":"caa-cerebral-amyloid-angiopathy","name":"caa cerebral amyloid angiopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05734378","title":"Prognosis of Cerebral Small Vessel Disease","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06960538","title":"Enpowering Progression Risk of Cerebral Amyloid Angiopathy","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","has_results":false},{"nct_id":"NCT06933212","title":"Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.","phase":"","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","has_results":false},{"nct_id":"NCT05773235","title":"MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}